Europska Unija - engleski - EMA (European Medicines Agency)

nordic group b.v. - methotrexate - arthritis, psoriatic, psoriasis, arthritis, juvenile rheumatoid, arthritis, rheumatoid - antineoplastic agents, - nordimet is indicated for the treatment of:active rheumatoid arthritis in adult patients,polyarthritic forms of severe, active juvenile idiopathic arthritis (jia), when the response to nonsteroidal anti-inflammatory drugs (nsaids) has been inadequate,severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, psoralens and ultraviolet a (puva), and retinoids, and severe psoriatic arthritis in adult patients.

Irska - engleski - HPRA (Health Products Regulatory Authority)

boehringer ingelheim international gmbh - meloxicam - tablet - 15 milligram(s) - oxicams; meloxicam

Malta - engleski - Medicines Authority

boehringer ingelheim international gmbh binger strasse 173, 55216 ingelheim am rhein, germany - meloxicam - tablet - meloxicam 15 mg - antiinflammatory and antirheumatic products

Irska - engleski - HPRA (Health Products Regulatory Authority)

boehringer ingelheim international gmbh - meloxicam - tablet - 7.5 milligram(s) - oxicams; meloxicam

Malta - engleski - Medicines Authority

boehringer ingelheim international gmbh binger strasse 173, 55216 ingelheim am rhein, germany - meloxicam - tablet - meloxicam 7.5 mg - antiinflammatory and antirheumatic products

Kanada - engleski - Health Canada

organon canada inc. - mometasone furoate - cream - 0.1% - mometasone furoate 0.1% - anti-inflammatory agents

Kanada - engleski - Health Canada

organon canada inc. - mometasone furoate - lotion - 0.1% - mometasone furoate 0.1% - anti-inflammatory agents

Kanada - engleski - Health Canada

organon canada inc. - mometasone furoate - ointment - 0.1% - mometasone furoate 0.1% - anti-inflammatory agents